ArticleTherapeutic advances in medical oncology2026
Risk stratification and boost dose optimization for locoregionally advanced nasopharyngeal carcinoma with residual lesions based on clinical stage and post-radiotherapy EBV DNA.
Xinyi Hong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.